Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Transplantation Retrieve available abstracts of 59 articles: HTML format

Single Articles

September 2025
1. MASPERO M, Sposito C, Wehrle C, Bongini M, et al
   Post-recurrence Survival After Liver Transplantation for Hepatocellular Carcinoma.
   Transplantation. 2025 Sep 8. doi: 10.1097/TP.0000000000005514.
   PubMed     Abstract available
   
   
   August 2025
2. YANG M, Wang J, Li C, Yang Z, et al
   Serine Glycine Restriction Aggravates Hepatic Ischemia-reperfusion Injury.
   Transplantation. 2025 Aug 22. doi: 10.1097/TP.0000000000005487.
   PubMed     Abstract available
   
   
   July 2025
3. MALIK AK, Mann DA
   Comment on "G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression".
   Transplantation. 2025 Jul 11. doi: 10.1097/TP.0000000000005499.
   PubMed    
   
   
   May 2025
4. XIE C, Qiu N, Wang C, Chen J, et al
   G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression.
   Transplantation. 2025 May 8. doi: 10.1097/TP.0000000000005412.
   PubMed     Abstract available
   
   
   
5. MONTI C, Hong SK, Lee A, Hong JC, et al
   Acute Response of Hepatocyte MRP2 Internalization as an Indicator of Ischemia-Reperfusion Injury in Liver Transplantation.
   Transplantation. 2025 May 5. doi: 10.1097/TP.0000000000005418.
   PubMed     Abstract available
   
   
   
6. MALIK TH, Keeney E, Jang A, Hafeez MS, et al
   Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis.
   Transplantation. 2025;109:823-831.
   PubMed     Abstract available
   
   
   April 2025
7. HONG G, Han DK, Rhu J, Hong SK, et al
   Safety and Therapeutic Outcomes of Adjuvant Immunotherapy With Autologous Cytokine-induced Killer Cells for Patients With Hepatocellular Carcinoma Beyond Milan Criteria After Liver Transplantation.
   Transplantation. 2025 Apr 16. doi: 10.1097/TP.0000000000005406.
   PubMed     Abstract available
   
   
   
8. THULUVATH AJ, Polineni P, Morrissey S, Belfanti K, et al
   Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study.
   Transplantation. 2025;109:e202-e212.
   PubMed     Abstract available
   
   
   March 2025
9. WEHRLE CJ, Kusakabe J, Nakayama T, Miller C, et al
   Time to Expand Selection Criteria for MELD Exception Points in Liver Transplantation for Hepatocellular Carcinoma.
   Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005396.
   PubMed    
   
   
   
10. YAKUBU I, Spengler J, Taylor P, LaPorte M, et al
    Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients.
    Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005361.
    PubMed     Abstract available
    
    
    February 2025
11. LACOM C, Kothari RP, Mendez NV, Galli A, et al
    Safety and Feasibility of Early Extubation in Liver Transplantation: Experience in 1555 Patients.
    Transplantation. 2025 Feb 14. doi: 10.1097/TP.0000000000005356.
    PubMed     Abstract available
    
    
    January 2025
12. LI Z, Raptis D, Rammohan A, Gunasekaran V, et al
    Validation of a Pretransplant Risk Prediction Model for Early Allograft Dysfunction After Living-donor Liver Transplantation.
    Transplantation. 2025 Jan 28. doi: 10.1097/TP.0000000000005331.
    PubMed     Abstract available
    
    
    
13. GU Y, Li Y, Zhang C, Liu Y, et al
    BCL6 Alleviates Hepatic Ischemia/Reperfusion Injury Via Recruiting SIRT1 to Repress the NF-kappaB/NLRP3 Pathway.
    Transplantation. 2025 Jan 13. doi: 10.1097/TP.0000000000005305.
    PubMed     Abstract available
    
    
    
14. SAKOWITZ S, Bakhtiyar SS, Mallick S, Kaldas F, et al
    Association of Community Socioeconomic Distress With Waitlist and Survival Outcomes in Liver Transplantation.
    Transplantation. 2025 Jan 9. doi: 10.1097/TP.0000000000005328.
    PubMed     Abstract available
    
    
    
15. MANKOWSKI MA, Wood NL, Massie AB, Segev DL, et al
    Targeted Broader Sharing for Liver Continuous Distribution.
    Transplantation. 2025;109:e36-e44.
    PubMed     Abstract available
    
    
    December 2024
16. JATANA S, Krys D, Verhoeff K, Kung JY, et al
    Liver Allograft Cirrhosis, Retransplant, and Mortality Secondary to Recurrent Disease After Transplant for MASH: A Systematic Review and Meta-analysis.
    Transplantation. 2024 Dec 11. doi: 10.1097/TP.0000000000005276.
    PubMed     Abstract available
    
    
    November 2024
17. MAGYAR CTJ, Perera S, Rajendran L, Li Z, et al
    Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
    Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005240.
    PubMed     Abstract available
    
    
    October 2024
18. NAM HJ, Kim DG, Min EK, Lee JG, et al
    Preoperative Factors Affecting Graft Survival After ABO-incompatible Adult Liver Transplantation.
    Transplantation. 2024 Oct 23. doi: 10.1097/TP.0000000000005231.
    PubMed     Abstract available
    
    
    
19. SATAPATHY SK, Elwir S, Brandman D, Smith C, et al
    Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH Consortium.
    Transplantation. 2024 Oct 22. doi: 10.1097/TP.0000000000005236.
    PubMed     Abstract available
    
    
    
20. MATSUMOTO R, Verna EC, Rosenblatt R, Emond JC, et al
    No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD Era.
    Transplantation. 2024;108:2100-2108.
    PubMed     Abstract available
    
    
    September 2024
21. BERARDI G, Guglielmo N, Cucchetti A, Usai S, et al
    Transarterial Radioembolization Can Downstage Intermediate and Advanced Hepatocellular Carcinoma to Liver Transplantation.
    Transplantation. 2024 Sep 17. doi: 10.1097/TP.0000000000005204.
    PubMed     Abstract available
    
    
    
22. JO HS, Kim DS, Cho JY, Hwang S, et al
    Comparison of Clinical Outcomes Using Left and Right Liver Grafts in Adult-to-adult Living-donor Liver Transplantation: A Retrospective Cohort Study Using the Korean Organ Transplantation Registry.
    Transplantation. 2024 Sep 9. doi: 10.1097/TP.0000000000005200.
    PubMed     Abstract available
    
    
    July 2024
23. KRISHNAN SK, Ramakrishna SH, Malleeswaran S, Kasala MB, et al
    Auxiliary Partial Orthotopic Liver Transplantation Is a Safe and Effective Option for Yellow Phosphorus Toxin-induced Acute Liver Failure.
    Transplantation. 2024 Jul 24. doi: 10.1097/TP.0000000000005163.
    PubMed     Abstract available
    
    
    
24. TANAKA T, Ross-Driscoll K, Pancholia S, Axelrod D, et al
    Body Size Remains the Major Source of Sex Disparity Despite Updated Liver Transplant Allocation Policies.
    Transplantation. 2024 Jul 18. doi: 10.1097/TP.0000000000005142.
    PubMed     Abstract available
    
    
    June 2024
25. WEHRLE CJ, Kusakabe J, Akabane M, Maspero M, et al
    Expanding Selection Criteria in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: Long-term Follow-up of a National Registry and 2 Transplant Centers.
    Transplantation. 2024 Jun 4. doi: 10.1097/TP.0000000000005097.
    PubMed     Abstract available
    
    
    May 2024
26. FRANCOZ C, Joly D, Legendre C
    Liver Transplantation for Polycystic Liver Disease: Definitely not a Cosmetic Surgery.
    Transplantation. 2024 May 21. doi: 10.1097/TP.0000000000005066.
    PubMed    
    
    
    
27. CILLO U, Lauterio A, Furlanetto A, Canitano N, et al
    Full-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion.
    Transplantation. 2024 May 17. doi: 10.1097/TP.0000000000005039.
    PubMed     Abstract available
    
    
    
28. ZHAN M, Liu D, Yao L, Wang W, et al
    Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway.
    Transplantation. 2024 May 10. doi: 10.1097/TP.0000000000005036.
    PubMed     Abstract available
    
    
    April 2024
29. CONCORS SJ, Hernandez PT, O'Brien C, DePaolo J, et al
    Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
    Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005042.
    PubMed     Abstract available
    
    
    
30. RAJAKANNU M, Rammohan A, Narasimhan G, Murugesan S, et al
    Deceased Donor Liver Transplantation in India: First Report of 5-Y Outcomes.
    Transplantation. 2024 Apr 19. doi: 10.1097/TP.0000000000004991.
    PubMed     Abstract available
    
    
    
31. EMAMAULLEE J, Bartlett JMA, Bangerth S, Etesami K, et al
    Response Regarding Application of the CHALF Score in Pediatric Acute Liver Failure.
    Transplantation. 2024;108:e66-e67.
    PubMed    
    
    
    
32. YADAV D, Lal BB, Sood V, Khanna R, et al
    Prognostication in Pediatric Acute Liver Failure Using CHALF Score-"Perspective From the Opposite Shore".
    Transplantation. 2024;108:e64-e65.
    PubMed    
    
    
    March 2024
33. MIYAKE K, Kim DY, Chau LC, Trudeau S, et al
    Exception Policy Change Increased the Simultaneous Kidney-liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004950.
    PubMed     Abstract available
    
    
    
34. ISHAQUE T, Beckett J, Gentry S, Garonzik-Wang J, et al
    Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004957.
    PubMed     Abstract available
    
    
    February 2024
35. BECKER EC, Siddique O, O'Sullivan DM, Dar W, et al
    Disparities in Liver Transplantation for Nonalcoholic Steatohepatitis in Women.
    Transplantation. 2024 Feb 29. doi: 10.1097/TP.0000000000004964.
    PubMed     Abstract available
    
    
    
36. TOSHIMA T, Harada N, Itoh S, Tomiyama T, et al
    What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation?
    Transplantation. 2024 Feb 27. doi: 10.1097/TP.0000000000004952.
    PubMed     Abstract available
    
    
    
37. MIYAKE K, Chau LC, Trudeau S, Kitajima T, et al
    Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.
    Transplantation. 2024 Feb 27. doi: 10.1097/TP.0000000000004955.
    PubMed     Abstract available
    
    
    
38. ELSOKARY K, Samuel S, Koizumi N, Ortiz J, et al
    Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Transplantation. 2024;108:e21.
    PubMed    
    
    
    
39. CROSS-NAJAFI AA, Farag K, Chen AM, Smith LJ, et al
    The Long Road to Develop Custom-built Livers: Current Status of 3D Liver Bioprinting.
    Transplantation. 2024;108:357-368.
    PubMed     Abstract available
    
    
    January 2024
40. JAN MY, Patidar KR, Ghabril MS, Kubal CA, et al
    Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities.
    Transplantation. 2024 Jan 9. doi: 10.1097/TP.0000000000004851.
    PubMed     Abstract available
    
    
    December 2023
41. SCHMIDT K, Spann A, Khan MQ, Izzy M, et al
    Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation.
    Transplantation. 2023 Dec 7. doi: 10.1097/TP.0000000000004875.
    PubMed     Abstract available
    
    
    
42. ZHOU K, Lit A, Kuo LS, Thompson LK, et al
    Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.
    Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004888.
    PubMed     Abstract available
    
    
    November 2023
43. KUSAKABE J, Kozato A, Tajima T, Bekki Y, et al
    Reappraisal of Donor Age in Liver Transplantation: NASH as a Potential Target to Safely Utilize Old Liver Grafts.
    Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004865.
    PubMed     Abstract available
    
    
    
44. RASTOGI A, Gupta AA, Piplani T, Yadav KS, et al
    Hilar Anatomy in 3035 Living Liver Donors: A Novel Classification for Donor Surgery and Suitability, Hepatic Surgeries, and Hepatobiliary Interventions.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004807.
    PubMed     Abstract available
    
    
    
45. MAHMUD N, Yagan L, Hoteit MA, Reddy KR, et al
    Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004860.
    PubMed     Abstract available
    
    
    
46. SNEIDERS D, van Dijk ARM, Darwish-Murad S, van Rosmalen M, et al
    Quantifying the Disadvantage of Small Recipient Size on the Liver Transplantation Waitlist, a Longitudinal Analysis Within the Eurotransplant Region.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004804.
    PubMed     Abstract available
    
    
    
47. WANG JH, Pfeiffer RM, Musgrove D, Castenson D, et al
    Cancer Mortality Among Solid Organ Transplant Recipients in the United States During 1987-2018.
    Transplantation. 2023;107:2433-2442.
    PubMed     Abstract available
    
    
    October 2023
48. SEDKI M, Kwong A, Bhargava M, Ahmed A, et al
    Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
    Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004800.
    PubMed     Abstract available
    
    
    
49. ASCHER-BARTLETT JM, Bangerth S, Jordan S, Weaver C, et al
    CHALF Score: A Novel Tool to Rapidly Risk Stratify Children in Need of Liver Transplant Evaluation During Acute Liver Failure.
    Transplantation. 2023 Oct 23. doi: 10.1097/TP.0000000000004845.
    PubMed     Abstract available
    
    
    
50. DEEP A
    Organ Allocation in Children With Chronic Liver Disease: Quest for an Ideal Prognostic Model Continues!
    Transplantation. 2023;107:e242-e244.
    PubMed    
    
    
    
51. AHN DJ, Zeng S, Pelzer KM, Barth RN, et al
    The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
    Transplantation. 2023;107:e247-e256.
    PubMed     Abstract available
    
    
    
52. ZENDEL A, Renzo CD, Rocha C, Samuel B, et al
    P5.3: Successful liver transplantation using a deceased donor liver with glycogenic hepatopathy pathologic appearance.
    Transplantation. 2023;107.
    PubMed    
    
    
    
53. RODRIGUEZ-DAVALOS MI, Lopez-Verdugo F, Kasahara M, Muiesan P, et al
    International Liver Transplantation Society Global Census: First Look at Pediatric Liver Transplantation Activity Around the World.
    Transplantation. 2023;107:2087-2097.
    PubMed     Abstract available
    
    
    September 2023
54. AZOULAY D, Desterke C, Bhangui P, Serrablo A, et al
    Rescue Liver Transplantation for Posthepatectomy Liver Failure: A Systematic Review and Survey of an International Experience.
    Transplantation. 2023 Sep 26. doi: 10.1097/TP.0000000000004813.
    PubMed     Abstract available
    
    
    August 2023
55. ROSENTHAL BE, Abt PL, Schaubel DE, Reddy KR, et al
    Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Transplantation. 2023 Aug 28. doi: 10.1097/TP.0000000000004767.
    PubMed     Abstract available
    
    
    July 2023
56. THULUVATH AJ, Duarte-Rojo A, Lai JC, Peipert J, et al
    Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant Candidates.
    Transplantation. 2023 Jul 27. doi: 10.1097/TP.0000000000004741.
    PubMed     Abstract available
    
    
    
57. HASSOUNEH R, Flynn S, Shen S, Tseng M, et al
    Impact of Liver Transplantation on Adipose Tissue Compartments and Its Association With Metabolic Sequela.
    Transplantation. 2023 Jul 12. doi: 10.1097/TP.0000000000004704.
    PubMed     Abstract available
    
    
    
58. BRANAGAN WT, Norvell JP
    Assessment and Evaluation of Alcohol Use Disorder in Liver Transplant.
    Transplantation. 2023 Jul 6. doi: 10.1097/TP.0000000000004722.
    PubMed     Abstract available
    
    
    June 2023
59. COTTER TG, Mitchell MC, Patel MJ, Anouti A, et al
    Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Transplantation. 2023 Jun 21. doi: 10.1097/TP.0000000000004701.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.